Here we train cis-regulatory models of prostate tissue gene expression and impute expression transcriptome-wide for 233,955 European ancestry men (14,616 prostate cancer (PrCa) cases, 219,339 controls) from two large cohorts. Among 12,014 genes evaluated in the UK Biobank, we identify 38 associated with PrCa, many replicating in the Kaiser Permanente RPGEH. We report the association of elevated TMPRSS2 expression with increased PrCa risk (independent of a previously-reported risk variant) and with increased tumoral expression of the TMPRSS2:ERG fusion-oncogene in The Cancer Genome Atlas, suggesting a novel germline-somatic interaction mechanism. Three novel genes, HOXA4, KLK1, and TIMM23, additionally replicate in the RPGEH cohort. Furtherm...
Prostate cancer (PrCa) is highly heritable; 284 variants have been identified to date that are assoc...
Tremendous advances in genomic capabilities, including high-throughput genotyping technology and alg...
International audienceProstate cancer (PrCa) is the second most common malignancy in men. More than ...
Genome-wide association study-identified prostate cancer risk variants explain only a relatively sma...
Genome-wide association study-identified prostate cancer risk variants explain only a relatively sma...
Genome-wide association study-identified prostate cancer risk variants explain only a relatively sma...
Although genome-wide association studies (GWAS) for prostate cancer (PrCa) have identified more than...
Transcriptional dysregulation is a hallmark of prostate cancer (PCa). We mapped the RNA polymerase I...
Transcriptional dysregulation is a hallmark of prostate cancer (PCa). We mapped the RNA polymerase I...
Although genome-wide association studies (GWAS) for prostate cancer (PrCa) have identified more than...
Genome wide association studies have identified an increasing number of common germline variants (CV...
Genome-wide association study–identified prostate cancer risk variants explain only a relatively sma...
Many genetic variants affect disease risk by altering context-dependent gene regulation. Such varian...
Numerous Genome Wide Association (GWA) studies of large populations have provided limited biomarkers...
Background Understanding the heterogeneous genotypes and phenotypes of prostate cancer is fundamenta...
Prostate cancer (PrCa) is highly heritable; 284 variants have been identified to date that are assoc...
Tremendous advances in genomic capabilities, including high-throughput genotyping technology and alg...
International audienceProstate cancer (PrCa) is the second most common malignancy in men. More than ...
Genome-wide association study-identified prostate cancer risk variants explain only a relatively sma...
Genome-wide association study-identified prostate cancer risk variants explain only a relatively sma...
Genome-wide association study-identified prostate cancer risk variants explain only a relatively sma...
Although genome-wide association studies (GWAS) for prostate cancer (PrCa) have identified more than...
Transcriptional dysregulation is a hallmark of prostate cancer (PCa). We mapped the RNA polymerase I...
Transcriptional dysregulation is a hallmark of prostate cancer (PCa). We mapped the RNA polymerase I...
Although genome-wide association studies (GWAS) for prostate cancer (PrCa) have identified more than...
Genome wide association studies have identified an increasing number of common germline variants (CV...
Genome-wide association study–identified prostate cancer risk variants explain only a relatively sma...
Many genetic variants affect disease risk by altering context-dependent gene regulation. Such varian...
Numerous Genome Wide Association (GWA) studies of large populations have provided limited biomarkers...
Background Understanding the heterogeneous genotypes and phenotypes of prostate cancer is fundamenta...
Prostate cancer (PrCa) is highly heritable; 284 variants have been identified to date that are assoc...
Tremendous advances in genomic capabilities, including high-throughput genotyping technology and alg...
International audienceProstate cancer (PrCa) is the second most common malignancy in men. More than ...